ShockWave Medical, Inc. (SWAV): Price and Financial Metrics
SWAV Price/Volume Stats
| Current price | $334.75 | 52-week high | $334.90 |
| Prev. close | $334.83 | 52-week low | $157.00 |
| Day low | $334.71 | Volume | 4,714,600 |
| Day high | $334.90 | Avg. volume | 968,088 |
| 50-day MA | $325.08 | Dividend yield | N/A |
| 200-day MA | $240.56 | Market Cap | 12.57B |
SWAV Stock Price Chart Interactive Chart >
ShockWave Medical, Inc. (SWAV) Company Bio
Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
SWAV Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 90.91% |
| 3-year | 72.63% |
| 5-year | 769.71% |
| YTD | 75.67% |
| 2023 | -7.32% |
| 2022 | 15.30% |
| 2021 | 71.93% |
| 2020 | 136.16% |
| 2019 | N/A |
Loading social stream, please wait...